- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity
Total 2568 results
-
Vaccinex Inc.Merck Sharp & Dohme LLCRecruitingRecurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)United States
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingRecurrent Skin Squamous Cell Carcinoma | Resectable Skin Squamous Cell Carcinoma | Stage I Skin Cancer | Stage II Skin Cancer | Stage III Skin CancerUnited States
-
The University of Hong KongRecruitingPredicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine LearningOral Squamous Cell CarcinomaHong Kong
-
Fayoum UniversityCompletedOral Squamous Cell CarcinomaEgypt
-
Akamis BioRecruitingSquamous Cell Carcinoma of the Head and NeckUnited Kingdom
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; GORTEC (Head and Neck Oncology and Radiotherapy...Active, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, Korea, Republic of, Taiwan, China, Argentina, France, Japan, Israel, United Kingdom, Belgium, Germany, Portugal, Greece, Italy, Georgia, Australia, Czechia, Brazil, Canada, Austria, Russian Federation, Switzerland and more
-
Boehringer IngelheimCompleted
-
Ulrich KeilholzCharite University, Berlin, Germany; AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckGermany
-
Debiopharm International SACompletedSquamous Cell Carcinoma of the Head and NeckFrance, Switzerland
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Italy, Japan, Spain, Taiwan, Korea, Republic of, France, Poland, Russian Federation, Turkey
-
Hellenic Cooperative Oncology GroupAstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckGreece
-
International Atomic Energy AgencyTata Memorial Centre; University of Maryland, College Park; Centro de Lucha contra... and other collaboratorsUnknownSquamous Cell Carcinoma of the Head and NeckIndia, Argentina, Cuba, Indonesia, Pakistan, Philippines, South Africa, Thailand, Uruguay
-
Merck KGaA, Darmstadt, GermanyCompletedSquamous Cell Carcinoma of the Head and NeckChina
-
Beth Israel Medical CenterCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Krzysztof MisiukiewiczSanofi; Icahn School of Medicine at Mount SinaiCompleted
-
Karolinska University HospitalUnknownSquamous Cell Carcinoma of the Head and NeckDenmark, Sweden
-
AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckCroatia, Sweden, United States, Czech Republic, Italy, Russian Federation, South Africa, Spain, United Kingdom, Estonia, Latvia, Lithuania, Norway, Canada, Netherlands, Argentina, Belgium, Greece, Thailand, India, Israel, Malaysia, ... and more
-
National Cancer Institute (NCI)CompletedRecurrent Neuroendocrine Carcinoma of the Skin | Stage III Neuroendocrine Carcinoma of the Skin | Stage IV Neuroendocrine Carcinoma of the Skin | Stage II Neuroendocrine Carcinoma of the Skin | Stage I Neuroendocrine Carcinoma of the SkinUnited States
-
Jinsong HouFirst Affiliated Hospital, Sun Yat-Sen University; Second Affiliated Hospital... and other collaboratorsRecruitingCarcinoma, Squamous CellChina
-
Danish Head and Neck Cancer GroupCompletedCancer of the Head and NeckDenmark
-
AstraZenecaPRA Health SciencesCompletedRecurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and NeckUnited States, Belgium, Canada, France, Spain, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Germany, Georgia, Israel, Czechia
-
Jonathan Schoenfeld, MD, MPHNaverisRecruitingHPV Positive Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC... and other conditionsUnited States
-
Tampere University HospitalOlfactomics OyRecruitingOral Squamous Cell CarcinomaFinland
-
Xin-Hua XuRecruitingOral Squamous Cell CarcinomaChina
-
Rowan UniversityRutgers UniversityRecruiting
-
Cliniques universitaires Saint-Luc- Université...RecruitingSquamous Cell Carcinoma of the Head and NeckBelgium
-
Medical University InnsbruckTerminatedHead and Neck NeoplasmsAustria
-
University of Colorado, DenverCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Acerta Pharma BVMerck Sharp & Dohme LLCCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Grupo de Investigación Clínica en Oncología RadioterapiaCompletedSquamous Cell Carcinoma of the Head and NeckSpain
-
University of ChicagoWithdrawnSquamous Cell Carcinoma of the Head and NeckUnited States
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Brigham and Women's HospitalCompletedC-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and NeckHead and Neck NeoplasmsUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Sanofi; Beth Israel Deaconess Medical Center; Brigham...CompletedSquamous Cell Carcinoma | Carcinoma of Head and/or NeckUnited States
-
Shanghai Jiao Tong University School of MedicineCompletedSurgery | Neoadjuvant Therapy | Oral Squamous Cell Carcinoma | RadiotherapyChina
-
Associazione Volontari Pazienti OncologiciMario Negri Institute for Pharmacological ResearchCompletedHead and Neck Squamous Cell CarcinomaItaly
-
University of Colorado, DenverAstraZenecaActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States
-
Groupe Oncologie Radiotherapie Tete et CouCompletedSquamous Cell Carcinoma of the Head and NeckFrance
-
CellSight Technologies, Inc.Stanford UniversityCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Assiut UniversityCompletedSquamous Cell Carcinoma of the Head and NeckEgypt
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLC; Institute of Cancer Research, United KingdomTerminatedSquamous Cell Carcinoma of the Head and Neck | Squamous Cell CarcinomaUnited Kingdom
-
PfizerTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, China, Taiwan, France, Australia, Hungary, Korea, Republic of, Germany, Japan, Switzerland, Ireland, Israel, United Kingdom, Italy, Poland, Belgium, Canada, Greece, Portugal, Austria, Russian Federation
-
Sanford HealthCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
University of Maryland, BaltimoreNational Institute of Dental and Craniofacial Research (NIDCR)CompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Washington University School of MedicineNovartis PharmaceuticalsCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
HiberCell, Inc.Merck Sharp & Dohme LLCTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Comprehensive Cancer Network; Vanderbilt-Ingram Cancer CenterTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States
-
SanofiCompletedHead and Neck NeoplasmsChina
-
University Health Network, TorontoCompletedSquamous Cell Carcinoma of the Head and NeckCanada